Jean Nicolas Trebouta
Direktor/Vorstandsmitglied bei VALERIO THERAPEUTICS
Ursprung des Netzwerks ersten Grades von Jean Nicolas Trebouta
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 35 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jean Nicolas Trebouta
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Aventis, Inc. | Corporate Officer/Principal Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | ||
| STALLERGENES | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal Director of Finance/CFO | |
| MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Bertin Technologies SAS
 Bertin Technologies SAS Electronic Equipment/InstrumentsElectronic Technology Bertin Technologies SAS provides technical assistance and consulting services. It engages in developing and advising customers on electronic, optical, telecom, energy, biotech, and mechanical systems. The firm serves in the fields of energy, environment, life sciences, defense, and aerospace sectors. The company was founded in 1956 and is headquartered in Montigny-Le-Bretonneux, France. | Electronic Equipment/Instruments | Director/Board Member | |
SPI-bio SA
 SPI-bio SA Miscellaneous Commercial ServicesCommercial Services SPI-bio SA develops and markets immunological reagents and kits for xenobiotics and endogenous molecules. It assists clients from screening of candidate drugs to manufacturing and distribution of clinical supplies. The company was founded in 1991 and is headquartered in Massy, France. | Miscellaneous Commercial Services | Director/Board Member | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ABLYNX | Biotechnology | Chairman Chairman | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member | |
| NANOBIOTIX | Medical Specialties | Chairman Chief Tech/Sci/R&D Officer | |
| AB SCIENCE | Pharmaceuticals: Other | Director/Board Member Founder | |
Critical Care Diagnostics, Inc.
 Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
HRA Pharma Development SARL
 HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Pharmaceuticals: Major | Director/Board Member Founder | |
| PHARNEXT SCA | Biotechnology | Chief Executive Officer | |
| Weill Cornell Medical College | College/University | Doctorate Degree | |
Ellipse Pharmaceuticals SAS
 Ellipse Pharmaceuticals SAS Miscellaneous Commercial ServicesCommercial Services Part of Bertin Technologies SAS, Ellipse Pharmaceuticals SAS provides pharmaceutical and biotech consulting services. The company is based in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member | |
| WWS Holdings Ltd. | Director/Board Member | ||
LAB GmbH
 LAB GmbH Industrial MachineryProducer Manufacturing Part of Infraneo Structure & Rehabilitation SASU, LAB GmbH is a German company that manufactures refrigeration and air-conditioning equipment. The company is based in Stuttgart, Germany. Richard Budin has been the CEO of the company since 2019. LAB was acquired by Martin GmbH from CNIM Group SA on January 24, 2022. | Industrial Machinery | Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Director/Board Member Chairman Director/Board Member | |
| Babcock Wanson Caldeiras Lda. | Director/Board Member | ||
Babcock Wanson España
 Babcock Wanson España Building ProductsProducer Manufacturing Babcock Wanson España is a private company based in Erandio, Spain. The Spanish company manufactures and rents industrial boilers and burners. | Building Products | Director/Board Member | |
MES SELCHP Ltd.
 MES SELCHP Ltd. Investment ManagersFinance Part of iCON Infrastructure LLP, MES SELCHP Ltd. engages in equity investment. The company is based in London, UK. Founded in 1999. | Investment Managers | Director/Board Member | |
| ADVICENNE | Pharmaceuticals: Generic | Director/Board Member Chairman Director/Board Member | |
American Chamber of Commerce In Denmark
 American Chamber of Commerce In Denmark Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce in Denmark is an organization that provides news, events, membership forums, and resources related to business in Denmark. The American Chamber of Commerce in Denmark is based in Copenhagen, Denmark. The organization focuses on promoting transatlantic data flows and foreign direct investments. Recently, the Danish government announced that it will invest 143 billion kroner in defense over the next decade. The organization also holds more than 50 events a year, including seminars and workshops on topics such as workforce planning and Danish taxation for expats. | Miscellaneous Commercial Services | Director/Board Member | |
| EUROBIO SCIENTIFIC | Medical Specialties | Director/Board Member Director/Board Member | |
| Columbia University College of Physicians & Surgeons | College/University | Corporate Officer/Principal | |
| AKARI THERAPEUTICS, PLC | Biotechnology | Chief Executive Officer | |
| The Cass Foundation | Director/Board Member | ||
| OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
| Onxeo US | Chief Operating Officer Chairman | ||
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Chairman | |
Sund Capital ApS
 Sund Capital ApS Financial ConglomeratesFinance Sund Capital ApS provides investment services. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Chief Executive Officer | |
Silence Therapeutics GmbH
 Silence Therapeutics GmbH BiotechnologyHealth Technology Part of Silence Therapeutics Plc, Silence Therapeutics GmbH is a German biotechnology company that develops RNAi-based drugs. The company is based in Berlin, Germany and was founded in 2014. | Biotechnology | Chief Executive Officer | |
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
| Cemag-Care SA | Founder | ||
| PANTECH SA | Financial Conglomerates | Director/Board Member | |
| CNIM Escalators UK Ltd. | Director/Board Member | ||
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Biotechnology | Chairman Director/Board Member Director/Board Member |
Statistik
International
| Frankreich | 22 |
| Vereinigte Staaten | 9 |
| Vereinigtes Königreich | 8 |
| Dänemark | 4 |
| Belgien | 3 |
Sektoral
| Health Technology | 27 |
| Commercial Services | 6 |
| Consumer Services | 4 |
| Finance | 4 |
| Producer Manufacturing | 3 |
Operativ
| Director/Board Member | 221 |
| Independent Dir/Board Member | 77 |
| Chairman | 74 |
| Corporate Officer/Principal | 59 |
| Chief Executive Officer | 34 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Per Anders Göte Samuelsson | 36 |
| Bo Jesper Hansen | 34 |
| Russell Greig | 31 |
| Joseph Zakrzewski | 30 |
| Jean-Pierre Kinet | 26 |
| Michel Arié | 25 |
| Jean Bizzari | 24 |
| Patrick J. Langlois | 23 |
| Catherine Dunand | 23 |
| David Solomon | 22 |
| Graham Dixon | 18 |
| Elvira Sanz Urgoiti | 16 |
| Khalil Barrage | 15 |
| Dominique Costantini | 15 |
| André Ulmann | 11 |
- Börse
- Insiders
- Jean Nicolas Trebouta
- Unternehmensverbindungen
